| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 5 |
| 1 | ETOPOSIDE | 5 |
| 2 | BLEOMYCIN | 4 |
| 3 | BLEOMYCIN SULFATE | 4 |
| 4 | BEVACIZUMAB | 1 |
| 5 | IFOSFAMIDE | 1 |
| 6 | IFOSFAMIDE FOR INJECTION | 1 |
| 7 | TEMOZOLOMIDE | 1 |
| 8 | TRAMETINIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLEOMYCIN SULFATE | 4 | 0.0004 |
| 1 | ETOPOSIDE | 5 | 0.0001 |
| 2 | CISPLATIN | 5 | 0.0001 |
| 3 | TEMOZOLOMIDE | 1 | 0.0000 |
| 4 | IFOSFAMIDE FOR INJECTION | 1 | 0.0000 |
| 5 | TRAMETINIB | 1 | 0.0000 |
| 6 | BEVACIZUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 5 |
| 1 | Topoisomerase Inhibitor [EPC] | 5 |
| 2 | Alkylating Drug [EPC] | 2 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |
| 1 | Platinum-based Drug [EPC] | 5 | 0.0000 |
| 2 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |